ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The investment case for health technology in India is frequently overstated in one direction and understated in another
Muted movement reflects consolidation phase as investors await earnings triggers
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Subscribe To Our Newsletter & Stay Updated
